Abstracts

Olczak 2011 – Persistent behavioral impairments and alternations of brain dopamine system after early postnatal administration of thimerosal in rats

Nataf 2006 – Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity

Mostafa 2016 – The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder

Mostafa 2007 – Antineuronal antibodies in autistic children: relation to blood mercury

Mohamed 2015 – Assessment of Hair Aluminum, Lead, and Mercury in a Sample of Autistic Egyptian Children: Environmental Risk Factors of Heavy Metals in Autism

Minami 2009 – Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection

Maya 2006 – El timerosal y las enfermedades del neurodesarrollo infantil

Makani 2002 – Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway

Loison 2014 – Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization

Loison 2014 – Suppression by Thimerosal of Ex-Vivo CD4 T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells

Lohren – Toxicity of organic and inorganic mercury species in differentiated human neurons and human astrocytes

Li 2014 – Transcriptomic Analyses of Neurotoxic Effects in Mouse Brain After Intermittent Neonatal Administration of Thimerosal

Koh 2014 – Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients

Khaled – Altered urinary porphyrins and mercury exposure in biomarkers for autism severity in Egyptian children with autism spectrum disorders

Kern 2012 – Evidence of parallels between mercury intoxication and the brain pathology in autism

Kern 2010 – Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins

Juul-Dam 2001 – Prenatal, Perinatal, and Neonatal Factors in Autism, Pervasive Developmental Disorder-Not Otherwise Specified, and the General Population

James 2004 – Thimerosal Neurotoxicity is Associated with Glutathione Depletion: Protection with Glutathione Precursors

James 2004 – Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

Ida-Eto 2013 – Prenatal exposure to organomercury, thimerosal, persistently impairs the serotonergic and dopaminergic systems in the rat brain: Implications for association with developmental disorders

Ida-Eto 2011 – Embryonic exposure to thimerosal, an organomercury compound, causes abnormal early development of serotonergic neurons

Humphrey 2005 – Mitochondrial Mediated Thimerosal-Induced Apoptosis in a Human Neuroblastoma Cell Line (SK-N-SH)

Hornig 2004 – Neurotoxic effects of postnatal thimerosal are mouse strain dependent

Hooker 2014 – Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe

Holmes 2003 – Reduced Levels of Mercury in First Baby Haircuts of Autistic Children

Hewitson 2010 – Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study

Hewitson 2010 – Delayed Acquisition of Neonatal Reflexes in Newborn Primates Receiving a Thimerosal-Containing Hepatitis B Vaccine: Influence of Gestational Age and Birth Weight

Herbert 2005 – Large Brains in Autism: The Challenge of Pervasive Abnormality

Gronborg 2013 – Recurrence of Autism Spectrum Disorders in Full- and Half-Siblings and Trends Over Time, A Population-Based Cohort Study

Geier 2017 – Increased Risk for an Atypical Autism Diagnosis Following Thimerosal-containing Vaccine Exposure in the United States: A Prospective Longitudinal Case-Control Study in the Vaccine Study Datalink